MedDataX Logo

Evaluation of the Quality of the NovoSeven (rFVIIa) Tratment Practice at Rigshospitalet, Copenhagen University Hospital

NCT ID: NCT00192933

Last Updated: 2006-10-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Study Classification

OBSERVATIONAL

Study Start Date

2000-01-31

Study Completion Date

2010-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose is to evaluate and improve NovoSeven treatment practice done according to our guidelines

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hemorrhage Shock

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

DEFINED_POPULATION

Study Time Perspective

OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

NovoSeven treatment according to guideline

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Indication for NovoSeven treatment according to our guideline

Exclusion Criteria

\-
Minimum Eligible Age

0 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Rigshospitalet, Denmark

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pär Johansson, MD, MPA

Role: STUDY_CHAIR

Blood Bank, Rigshospitalet, Copenhagen University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Rigshospitalet, Copenhagen University Hospital

Copenhagen, , Denmark

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Pär Johansson, MD, MPA

Role: CONTACT

Phone: +45 3545 2030

Email: [email protected]

Jakob Stensballe, MD

Role: CONTACT

Phone: +45 3545 8269

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Pär Johansson, MD, MPA

Role: primary

Jakob Stensballe, MD

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2004-41-3996

Identifier Type: -

Identifier Source: org_study_id